1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: UKALL2003, NCT00222612
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 55 Sponsor: Other Protocol IDs: GMALL02, NCT00198978
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL01, NCT00198991
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 15 Sponsor: Other Protocol IDs: GMALL05, NCT00199082
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 0 to 75 Sponsor: Other Protocol IDs: LPA 2005, NCT00408278
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 and under Sponsor: Other Protocol IDs: LAL-BR/2001, NCT00526175
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and under Sponsor: Other Protocol IDs: LAL-AR-N-2005, NCT00526409
|
|
8.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and under Sponsor: Other Protocol IDs: 2007016, NCT00846703
|
|
9.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: LAL-AR/2003, NCT00853008
|
|
10.
|
Phase: Phase IV Type: Treatment Status: Active Age: 55 and over Sponsor: Other Protocol IDs: PETHEMA LAL-07FRAIL, NCT01358201
|
|
11.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: RJ-2010-56, NCT01358253
|
|
12.
|
Phase: Phase IV Type: Treatment Status: Active Age: 55 and over Sponsor: Other Protocol IDs: LAL-07OLD, NCT01366898
|
|
13.
|
Phase: Phase IV Type: Treatment Status: Active Age: 55 and under Sponsor: Other Protocol IDs: LAL Ph-2008, NCT01491763
|
|
14.
|
Phase: Phase IV Type: Treatment Status: Active Age: 14 to 70 Sponsor: Other Protocol IDs: hnslblzlzx2011-2, NCT01501149
|
|
15.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 60 Sponsor: Other Protocol IDs: LAL-AR/2011, NCT01540812
|
|
16.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: NILG-ALL 10/07, NCT00795756
|
|
17.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 65 and over Sponsor: Other Protocol IDs: GBG 52, 2008-003995-23, NCT01204437
|
|
18.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 1 to 17 Sponsor: Other Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331
|
|
19.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: ISG/OS-2, 2011-001659-36, NCT01459484
|
|
20.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NCI Protocol IDs: COG-ANHL1131, ANHL1131, NCT01595048
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CKTO-2000-06, HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000068827, IBCSG-22-00, EU-20119, EUDRACT-2005-005666-36, NCT00022516
|
|
23.
|
Phase: Phase III Type: Treatment Status: Active Age: 25 to 65 Sponsor: Other Protocol IDs: JALSG ALL202-O, NCT00131027
|
|
24.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 3 Sponsor: NCI Protocol IDs: COG-ACNS0334, ACNS0334, NCT00336024
|
|
25.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to under 30 Sponsor: NCI Protocol IDs: COG-AALL0433, AALL0433, NCT00381680
|